ZURICH Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.
- Hamburger chain Wendy's to reduce antibiotic use in beef supply
- Judge blocks Trump administration rules on contraceptive coverage
- Ebola victims sue Sierra Leone government over mismanaged funds
- Germany's Merck in fresh bid to enter U.S. MS pill market
- Cannabis ingredient holds promise as antipsychotic medicine
COPENHAGEN Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy.
(Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don’t have trouble sleeping, a recent study suggests.
(Reuters Health) - People who have so-called transient neurological attacks, including brief mini-strokes, may develop cognitive problems that linger for months, a recent study suggests.
(Reuters Health) - A California law allowing pharmacists to prescribe birth control sought to make it easier for women to obtain contraception, but few drug stores provide the service, a new study finds.